Finally, many tumours re-express E-cadherin in metastases, and in some tumour entities such as glioblastoma, breast carcinoma, or colon carcinoma, expression of E-cadherin is correlated with poor prognosis [153,154,155,156]. Here, CDH1 is linked to breast carcinoma.